• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
徐远志,孙宏骁,张晏维,等. 嗜黏蛋白阿克曼菌活菌制剂生产的冻干保护技术及机理[J]. 食品工业科技,2025,46(24):1−10. doi: 10.13386/j.issn1002-0306.2025010003.
引用本文: 徐远志,孙宏骁,张晏维,等. 嗜黏蛋白阿克曼菌活菌制剂生产的冻干保护技术及机理[J]. 食品工业科技,2025,46(24):1−10. doi: 10.13386/j.issn1002-0306.2025010003.
XU Yuanzhi, SUN Hongxiao, ZHANG Yanwei, et al. Development and Mechanistic Insights into Lyoprotective Technology for Akkermansia muciniphila Live Biotherapeutic Products[J]. Science and Technology of Food Industry, 2025, 46(24): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025010003.
Citation: XU Yuanzhi, SUN Hongxiao, ZHANG Yanwei, et al. Development and Mechanistic Insights into Lyoprotective Technology for Akkermansia muciniphila Live Biotherapeutic Products[J]. Science and Technology of Food Industry, 2025, 46(24): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025010003.

嗜黏蛋白阿克曼菌活菌制剂生产的冻干保护技术及机理

Development and Mechanistic Insights into Lyoprotective Technology for Akkermansia muciniphila Live Biotherapeutic Products

  • 摘要: 为了探究有效提高嗜黏蛋白-阿克曼菌(Akkermansia muciniphila,Akk)活菌数量的冻干保护剂组合及其相关机制,本研究以Akk DSM22959为研究对象,通过单因素实验和响应面试验对Akk DSM22959冻干保护剂的配比进行了优化,并通过分析菌粉的傅里叶红外光谱(Fourier-transform infrared spectroscopy, FTIR)、玻璃转化温度(Tg值)、Na+/K+ ATP酶活力、细胞膜完整性和扫描电镜(SEM)下的微观形态研究保护作用的机理。结果表明,在脱脂乳粉、麦芽糊精、谷氨酸钠、银耳多糖复配出的冻干保护剂保护作用下,经真空冷冻干燥的Akk DSM22959存活率为83.41%±0.41%;且在−20 ℃、4 ℃储藏60 d后Akk菌粉依然可以保持较高的存活率。所制备的冻干保护剂可在菌体表面形成保护层使Akk细胞膜保持完整,且在维持正常的生理形态的同时还具有较高的玻璃转化温度,显著降低了冻干过程对细胞膜的损伤并维持了细胞膜上的Na+/K+ ATP酶活力。总之,本研究为今后Akk活菌菌制剂的工业化生产提供了科学依据、奠定了应用基础。

     

    Abstract: To explore the optimal combination of lyoprotective agents for effectively enhancing the viability of Akkermansia muciniphila (Akk) and elucidating the underlying mechanisms.This study aimed to optimize lyoprotectant formulations using single-factor experiments and response surface methodology for freeze-drying (lyophilization) of Akk DSM 22959. Bacterial powder was analyzed using Fourier-transform infrared spectroscopy (FTIR), glass transition temperature (Tg), and scanning electron microscopy (SEM) and by assessing Na+/K+ ATPase activity and membrane integrity. The formulation sustained Na+/K+ ATPase activit and achieved a post-lyophilization viability of 83.41%±0.41%. The survival rate of Akk powder was still higher after storage at −20 ℃ and 4 ℃ for 60 days. The optimal lyoprotectant (composed of skim milk powder, maltodextrin, sodium glutamate, and tremella polysaccharides) formed a protective matrix that encapsulated the Akk cells. This matrix preserved membrane integrity, maintained physiological morphology, and elevated Tg, thereby substantially reducing cryo-injury during lyophilization.These findings provide critical mechanistic insights into lyoprotection strategies and establish a scalable protocol for industrial production of live Akk biotherapeutic products.

     

/

返回文章
返回